Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers.

The 32P-post-labelling assay for DNA adduct quantification gives the opportunity to examine endogenous exposure to DNA reactive compounds. Most human biomonitoring studies applied white blood cells (WBC) or cells obtained by broncho-alveolar lavages (BAL) as source of DNA, but still it is not clear what cell type represents the most reliable indicator for exposure to cigarette smoke-associated genotoxins. At first, we examined DNA adduct levels by means of nuclease P1 (NP1) enriched 32P-post-labelling in separated WBC subpopulations after in vitro incubations for 18 h with 10 microM benzo[a]pyrene (B[a]P). DNA adduct levels were highest in monocytes (10.7 +/- 2.9 adducts/10(8) nucleotides, n = 8), followed by lymphocytes (5.9 +/- 1.7, n = 8), and granulocytes (0.5 +/- 0.2, n = 8). Secondly, aromatic-DNA adduct levels were determined in BAL cells and WBC-subsets from (non-)smoking volunteers. In smoking individuals, adduct levels were in the ranking order: BAL cells (3.7 +/- 1.0, n = 5) > monocytes (2.0 +/- 0.5, n = 8) > or = lymphocytes (1.6 +/- 0.4, n = 8) > granulocytes (0.8 +/- 0.2, n = 8) by NP1-enrichment and monocytes (9.0 +/- 3.2, n = 5) > or = lymphocytes (8.0 +/- 2.1, n = 6) > granulocytes (2.1 +/- 0.3, n = 7) by butanol-enriched 32P-post-labelling. Aromatic-DNA adduct levels were significantly higher in WBC-subsets of smokers as compared with non-smokers, except for DNA adducts in granulocytes using butanol enrichment. Thirdly, dose-response relationships were investigated in mononuclear white blood cells (MNC, i.e. monocytes plus lymphocytes) and BAL-cells of a larger group of smoking individuals (n = 78). Adduct levels in MNC were related to daily exposure to cigarette-tar (r = 0.31, P < 0.01). Adduct levels in BAL cells seemed to be correlated with pack-years, but after correction for age this relationship was lost. Butanol extraction resulted in 5-6-fold higher DNA adduct levels in MNC, whereas butanol extraction of BAL-DNA of the same individuals yielded only 2-fold higher adduct levels. The two enrichment procedures of 32P-post-labelling were correlated in BAL cells (r = 0.86, P < 0.001, n = 12). We conclude that particularly MNC are good surrogates for the detection of smoking-related DNA adducts.

[1]  L. V. van't Veer,et al.  32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. , 1997, Mutation research.

[2]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[3]  M. Spitz,et al.  In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. , 1996, Cancer research.

[4]  S. Nesnow,et al.  Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. , 1995, Toxicology.

[5]  F P Perera,et al.  A molecular epidemiological case-control study of lung cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  J. Lewtas,et al.  DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. , 1995, Carcinogenesis.

[7]  K. Hemminki,et al.  Aromatic DNA adducts in larynx biopsies and leukocytes. , 1994, Carcinogenesis.

[8]  F J van Schooten,et al.  Formation of aromatic DNA adducts in white blood cells in relation to urinary excretion of 1-hydroxypyrene during consumption of grilled meat. , 1994, Carcinogenesis.

[9]  R. Stierum,et al.  Measurement by 32P-postlabeling of (+/-)anti-benzo[a]pyrene-diolepoxide-N2-deoxyguanosine adduct persistence in unstimulated human peripheral blood lymphocytes. , 1994, Mutation research.

[10]  K. Hemminki,et al.  Biological monitoring of exposure to polycyclic aromatic hydrocarbon in an electrode paste plant. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[11]  G. Hageman,et al.  DNA adduct and mutation analysis in white blood cells of smokers and nonsmokers , 1994, Environmental and molecular mutagenesis.

[12]  K. Hemminki,et al.  Analysis of cigarette-smoke-induced DNA adducts by butanol extraction and nuclease P1-enhanced 32P-postlabeling in human lymphocytes and granulocytes. , 1993, Environmental health perspectives.

[13]  N. Zanesi,et al.  DNA repair in human lymphocytes treated in vitro with (+)-anti- and (+/-)-syn-benzo[a]pyrene diolepoxide. , 1993, Mutation research.

[14]  D P Ford,et al.  Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  F. Perera,et al.  HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. , 1993, Carcinogenesis.

[16]  S. De Flora,et al.  Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer. , 1993, Environmental health perspectives.

[17]  F. Perera,et al.  Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells. , 1992, Carcinogenesis.

[18]  K. Hemminki,et al.  7-Methylguanine levels in DNA of smokers' and non-smokers' total white blood cells, granulocytes and lymphocytes. , 1992, Carcinogenesis.

[19]  W. Whong,et al.  Comparison of DNA adduct detection between two enhancement methods of the 32P-postlabelling assay in rat lung cells. , 1992, Mutation research.

[20]  L. Knudsen,et al.  Induction of DNA repair synthesis in human monocytes/B-lymphocytes compared with T-lymphocytes after exposure to N-acetoxy-N-acetylaminofluorene and dimethylsulfate in vitro. , 1992, Carcinogenesis.

[21]  S. De Flora,et al.  Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. , 1991, Carcinogenesis.

[22]  K. Hemminki,et al.  DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. , 1991, Carcinogenesis.

[23]  D. Phillips,et al.  Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells , 1990, International journal of cancer.

[24]  N. van Zandwijk,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. , 1990, Carcinogenesis.

[25]  J. Cuzick,et al.  DNA adducts in different tissues of smokers and non‐smokers , 1990, International journal of cancer.

[26]  F. Perera,et al.  Detection of adducts of deoxyribonucleic acid in white blood cells of roofers by 32P-postlabeling. Relationship of adduct levels to measures of exposure to polycyclic aromatic hydrocarbons. , 1990, Scandinavian journal of work, environment & health.

[27]  G. Lucier,et al.  Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. , 1990, Carcinogenesis.

[28]  H. Rüdiger,et al.  32P-postlabelling analysis of DNA adducts in monocytes of smokers and passive smokers , 1990, International archives of occupational and environmental health.

[29]  M. Tockman,et al.  Biological monitoring of fire fighters: sister chromatid exchange and polycyclic aromatic hydrocarbon-DNA adducts in peripheral blood cells. , 1989, Cancer research.

[30]  J. Lewtas,et al.  Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment. , 1989, Cancer letters.

[31]  R. C. Garner,et al.  Correlation of DNA adduct levels in human lung with cigarette smoking , 1988, Nature.

[32]  R. Gupta,et al.  Use of human peripheral blood lymphocytes to measure DNA binding capacity of chemical carcinogens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Nowak,et al.  Formation of dna adducts and water‐soluble metabolites of benzo[a]pyrene in human monocytes is genetically controlled , 1988, International journal of cancer.

[34]  M. V. Reddy,et al.  Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. , 1986, Carcinogenesis.

[35]  G. C. Farrell,et al.  Increased binding of benzo[a]pyrene metabolites to lymphocytes from patients with lung cancer. , 1986, Cancer letters.

[36]  H. Gelboin,et al.  Comparison of benzo(a)pyrene and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene metabolism in human blood monocytes and lymphocytes. , 1979, Cancer research.

[37]  A. Bøyum.  Isolation of lymphocytes, granulocytes and macrophages. , 1976, Scandinavian journal of immunology.